semaglutidesurvodutidetirzepatide
…, whereby researchers are investigating the use of subcutaneous semaglutide 2.4 mg/week for the treatment of adults with non-cirrhotic MASH…
8articles mentioning drugs
16drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Retatrutide ×
Retatrutide
This drug is selected. Its supporting articles are shown below.
Articles mentioning Retatrutide
8 articles · page 1 of 1semaglutideretatrutideRETALY3437943
…ed to a 4-fold reduction with the single GLP-1 receptor agonist semaglutide. Remarkably, the anti-tumor effects of RETA persisted after tre…
Ketamineretatrutidecannabispsychedelics
…ed clinical pipelines and unregulated street or online markets. Ketamine, psychedelics and cannabis are all under active clinical invest…
retatrutide
…an taking the unapproved next generation GLP-1 weight loss drug retatrutide made headlines in the national press last week.…
tirzepatideorforglipronphentermine-topiramateCagriSemanaltrexone-bupropionSubcutaneous semaglutidemazdutideliraglutide
… with naltrexone-bupropion, oral semaglutide, orforglipron, and tirzepatide (risk ratios from 3.1 to 4.2). Fatigue risk increased, particul…
retatrutideTirzepatidesomatostatinInsulinhyperaminoacidemiatype 2 diabeteshyperglucagonemialiver steatosisT2Dglucose-lowering therapies+2 more
…oncentrations, and similar observations have been reported with retatrutide despite its glucagon receptor agonist activity.9 Whether these …
Retatrutidetype 2 diabetesphase 3 trial
…Retatrutide, a triple action treatment for type 2 diabetes, could significa…